83
Views
0
CrossRef citations to date
0
Altmetric
Patent Evaluations

Use of a peptide enhancing the ability of radiation therapy to kill cancer cells: a patent evaluation of WO2012016918

, MD & , MD PhD
Pages 1485-1487 | Published online: 08 Aug 2012

Bibliography

  • Bao S, Wu Q, McLendon RE, Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-60
  • Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol 2012;22:233-44
  • An J, Chervin AS, Nie A, Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor. Oncogene 2007;26:652-61
  • Kobayashi J, Iwabuchi K, Miyagawa K, Current topics in DNA double-strand break repair. J Radiatry Res 2008;49:93-103
  • Quan EM, Li X, Li Y, A Comprehensive Comparison of IMRT and VMAT Plan Quality for Prostate Cancer Treatment. Int J Radiat Oncol Biol Phys 2012;83:1169-78
  • Nutting C, Dearnaley DP, Webb S. Intensity modulated radiation therapy: a clinical review. Br J Radiol 2000;73:459-69
  • Yao M, Lu M, Savvides PS, Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2012;83:684-9
  • Leblanc V, Tocque B, Delumeau I. Ras-GAP controls Rho-mediated cytoskeletal reorganization through its SH3 domain. Mol Cell Biol 1998;18:5567-78
  • Yang JY, Widmann C. Antiapoptotic signaling generated by caspase-induced cleavage of RasGAP. Mol Cell Biol 2001;21:5346-58
  • Yang JY, Widmann C. The RasGAP N-terminal fragment generated by caspase cleavage protects cells in a Ras/PI3K/Akt-dependent manner that does not rely on NFkappa B activation. J Biol Chem 2002;277:14641-6
  • Schwarze SR, Ho A, Vocero-Akbani A, In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999;285:1569-72
  • The University of Lausanne. Use of a peptide enhancing the ability of radiation therapy to kill cancer cells. WO2012016918; 2012
  • Michod D, Yang JY, Chen J, A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells. Oncogene 2004;23:8971-8
  • Michod D, Widmann C. TAT-RasGAP317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins. Mol Cancer Res 2007;5:497-507
  • Michod D, Annibaldi A, Schaefer S, Effect of RasGAP N2 fragment-derived peptide on tumor growth in mice. J Natl Cancer Inst 2009;101:828-32
  • Fischer J, Kolk A, Wolfart S, Future of local bone regeneration - protein versus gene therapy. J Craniomaxillofac Surg 2011;39:54-64
  • Oldfield EH, Ram Z, Culver KW, Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993;4:39-69
  • Shapiro AM, Lakey JR, Ryan EA, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-8
  • Shapiro AM, Ricordi C, Hering BJ, International trial of the edmonton protocol for islet transplantation. N Engl J Med 2006;355:1318-30
  • Park SJ, Shin S, Koo OJ, Functional improvement of porcine neonatal pancreatic cell clusters via conformal encapsulation using an air-driven encapsulator. Exp Mol Med 2012;44:20-5
  • Zhi ZL, Kerby A, King AJ, Nano-scale encapsulation enhances allograft survival and function of islets transplanted in a mouse model of diabetes. Diabetologia 2012;55:1081-90
  • Lee BR, Hwang JW, Choi YY, In situ formation and collagen-alginate composite encapsulation of pancreatic islet spheroids. Biomaterials 2012;33:837-45

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.